newsSanofi to acquire Principa Biopharma for $3.68 billion20 August 2020 | By Victoria Rees (European Pharmaceutical Review)Sanofi is set to acquire Principia Biopharma Inc. for a total aggregate equity value of $3.68 billion, at $100 per share.